Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease

被引:21
作者
Xu, Rui [1 ]
Xiao, Ganyuan [1 ]
Li, Yan [1 ]
Liu, Hongyan [1 ]
Song, Qing [1 ]
Zhang, Xiaoyu [1 ]
Yang, Ziyi [1 ]
Zheng, Yunxiaozhu [1 ]
Tan, Zhenghuai [2 ]
Deng, Yong [1 ]
机构
[1] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Dept Med Chem,Educ Minist, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Acad Chinese Med Sci, Inst Tradit Chinese Med Pharmacol & Toxicol, Chengdu 610041, Sichuan, Peoples R China
关键词
Alzheimer's disease; Benzo[d]isothiazol-3(2H)-one derivatives; Monoamine oxidase inhibitors; Acetylcholinesterase inhibitors; A beta aggregation inhibitors; Multifunctional agents; TARGET-DIRECTED LIGANDS; MANNICH BASE DERIVATIVES; NEUROPROTECTIVE PROPERTIES; BIOLOGICAL EVALUATION; OXIDATIVE STRESS; DESIGN; HYBRIDS; ANTIOXIDANT; DRUGS; ASSAY;
D O I
10.1016/j.bmc.2018.02.037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives were designed, synthesized and evaluated as potential multifunctional agents for the treatment of Alzheimer's disease (AD). The in vitro assays indicated that most of these derivatives were selective AChE inhibitors with good multifunctional properties. Among them, compounds 11b and 11d displayed comprehensive advantages, with good AChE (IC50 = 0.29 +/- 0.01 mu M and 0.46 +/- 0.02 mu M, respectively), MAO-A (IC50 = 8.2 +/- 0.08 mu M and 7.9 +/- 0.07 mu M, respectively) and MAO-B (IC50 = 20.1 +/- 0.16 mu M and 43.8 +/- 2.0% at 10 mu M, respectively) inhibitory activities, moderate self-induced A beta(1-42) aggregation inhibitory potency (35.4 +/- 0.42% and 48.0 +/- 1.53% at 25 mu M, respectively) and potential antioxidant activity. In addition, the two representative compounds displayed high BBB permeability in vitro. Taken together, these multifunctional properties make 11b and 11d as a promising candidate for the development of efficient drugs against AD. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1885 / 1895
页数:11
相关论文
共 45 条
[11]   Multitarget-Directed Benzylideneindanone Derivatives: Anti-β-Amyloid (Aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties against Alzheimer's Disease [J].
Huang, Ling ;
Lu, Chuanjun ;
Sun, Yang ;
Mao, Fei ;
Luo, Zonghua ;
Su, Tao ;
Jiang, Huailei ;
Shan, Wenjun ;
Li, Xingshu .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (19) :8483-8492
[12]   Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease [J].
Ismaili, Lhassane ;
Refouvelet, Bernard ;
Benchekroun, Mohamed ;
Brogi, Simone ;
Brindisi, Margherita ;
Gemma, Sandra ;
Campiani, Giuseppe ;
Filipic, Slavica ;
Agbaba, Danica ;
Esteban, Gerard ;
Unzeta, Mercedes ;
Nikolic, Katarina ;
Butini, Stefania ;
Marco-Contelles, Jose .
PROGRESS IN NEUROBIOLOGY, 2017, 151 :4-34
[13]   Structure of acetylcholinesterase complexed with E2020 (Aricept®):: implications for the design of new anti-Alzheimer drugs [J].
Kryger, G ;
Silman, I ;
Sussman, JL .
STRUCTURE, 1999, 7 (03) :297-307
[14]   Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors [J].
Legoabe, Lesetja J. ;
Petzer, Anel ;
Petzer, Jacobus P. .
BIOORGANIC CHEMISTRY, 2012, 45 :1-11
[15]   Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease [J].
Li, Ren-Shi ;
Wang, Xiao-Bing ;
Hu, Xiao-Jun ;
Kong, Ling-Yi .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (09) :2636-2641
[16]   Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition, anti-β-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer's disease [J].
Li, Yan ;
Qiang, Xiaoming ;
Luo, Li ;
Yang, Xia ;
Xiao, Ganyuan ;
Liu, Qi ;
Ai, Jiachen ;
Tan, Zhenghuai ;
Deng, Yong .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 126 :762-775
[17]   Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties [J].
Li, Yan ;
Qiang, Xiaoming ;
Luo, Li ;
Yang, Xia ;
Xiao, Ganyuan ;
Zheng, Yunxiaozhu ;
Cao, Zhongcheng ;
Sang, Zhipei ;
Su, Fu ;
Deng, Yong .
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (02) :714-726
[18]   Synthesis and evaluation of 4-hydroxyl aurone derivatives as multifunctional agents for the treatment of Alzheimer's disease [J].
Li, Yan ;
Qiang, Xiaoming ;
Luo, Li ;
Li, Yuxing ;
Xiao, Ganyuan ;
Tan, Zhenghuai ;
Deng, Yong .
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (10) :2342-2351
[19]   Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease [J].
Liston, DR ;
Nielsen, JA ;
Villalobos, A ;
Chapin, D ;
Jones, SB ;
Hubbard, ST ;
Shalaby, IA ;
Ramirez, A ;
Nason, D ;
White, WF .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 486 (01) :9-17
[20]   Design, synthesis and evaluation of chromone-2-carboxamido-alkylbenzylamines as multifunctional agents for the treatment of Alzheimer's disease [J].
Liu, Qiang ;
Qiang, Xiaoming ;
Li, Yan ;
Sang, Zhipei ;
Li, Yuxing ;
Tan, Zhenghuai ;
Deng, Yong .
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (05) :911-923